Vanguard PRIMECAP Inv (VPMCX)

138.76 -0.88  -0.63% Aug 11 USD
View Full Chart
Total Returns Chart

Key Stats

Net Asset Value 138.76
Turnover Ratio 5.00%
1 Year Fund Level Flows -6.647B

Performance & Returns

  Total Return Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M 2.75% 2.58% 45
3M 13.55% 15.84% 82
6M -3.73% 8.54% 96
YTD -0.26% 15.78% 96
1Y 13.28% 26.25% 90
3Y 12.47% 18.19% 88
5Y 12.51% 14.04% 68
10Y 15.03% 15.33% 58
15Y 10.74% 10.13% 38
20Y 7.90% 6.28% 16
As of Aug. 11, 2020. Returns for periods of 1 year and above are annualized.

Asset Allocation

Type % Net % Long % Short
Cash 2.60% 2.60% 0.00%
Stock 97.40% 97.40% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 0.00% 0.00% 0.00%
As of March 31, 2020

Region Exposure

Americas 83.19%
North America 83.19%
Latin America 0.00%
Greater Europe 11.03%
United Kingdom 2.61%
Europe Developed 8.42%
Europe Emerging 0.00%
Africa/Middle East 0.00%
Greater Asia 5.78%
Japan 1.86%
Australasia 0.00%
Asia Developed 0.00%
Asia Emerging 3.92%
Market Classification
% Developed Markets 96.08%
% Emerging Markets 3.92%
As of March 31, 2020. Region breakdown data is calculated by using the long position holdings of the portfolio.

Stock Sector Exposure

Basic Materials 0.64%
Communication Services 6.76%
Consumer Cyclical 8.80%
Consumer Defensive 0.03%
Energy 0.85%
Financial Services 7.97%
Healthcare 30.61%
Industrials 13.52%
Real Estate 0.00%
Technology 30.82%
Utilities 0.00%
As of March 31, 2020

Stock Market Capitalization

Giant 52.26%
Large 34.66%
Medium 12.25%
Small 0.75%
Micro 0.07%
As of March 31, 2020

Stock Style Exposure

Large Cap Value 23.79%
Large Cap Blend 30.71%
Large Cap Growth 32.63%
Mid Cap Value 8.11%
Mid Cap Blend 1.49%
Mid Cap Growth 2.45%
Small Cap Value 0.35%
Small Cap Blend 0.47%
Small Cap Growth 0.00%
As of March 31, 2020
View More Holdings

Top 10 Holdings

Symbol Name % Weight Price % Chg
LLY Eli Lilly and Co 5.84% 152.75 +1.41%
BIIB Biogen Inc 5.47% 293.47 +1.22%
ADBE Adobe Inc 5.28% 444.99 +2.24%
MSFT Microsoft Corp 4.96% 208.77 +2.65%
AMGN Amgen Inc 3.99% 241.20 +2.79%
TXN Texas Instruments Inc 3.31% 138.63 +1.90%
BABA Alibaba Group Holding Ltd ADR 2.97% 254.74 +2.54%
MU Micron Technology Inc 2.39% 47.48 -0.59%
AZN AstraZeneca PLC ADR 2.38% 56.85 +3.03%
LUV Southwest Airlines Co 2.23% 35.16 -0.37%
As of March 31, 2020
Advertisement

Basic Info

Investment Strategy
The investment seeks long-term capital appreciation. The fund invests in stocks considered to have above-average earnings growth potential that is not reflected in their current market prices. Its portfolio consists predominantly of large- and mid-capitalization stocks.
General
Security Type Mutual Fund
Oldest Share Symbol VPMCX
Equity Style Large Cap/Blend
Fixed Income Style --
Broad Asset Class US Equity
Broad Category Equity
Category Name Large Growth
Prospectus Objective Growth
Fund Owner Firm Name Vanguard
Benchmark Index
S&P 500 TR USD 100.0%
Reports
One Page Report Download

Manager Info

Name Tenure
Alfred Mordecai 20.60 yrs
James Marchetti 5.51 yrs
Joel Fried 31.61 yrs
M. Ansari 12.59 yrs
Theo Kolokotrones 35.19 yrs

Share Classes

Symbol Share Class
VPMAX Inst

Net Fund Flows

1M -761.76M
3M -1.910B
6M -3.753B
YTD -4.187B
1Y -6.647B
3Y -10.94B
5Y -14.51B
10Y -22.50B
As of July 31, 2020

Risk Info

Beta (5Y) 1.008
Historical Sharpe Ratio (10Y) 0.9771
Historical Sortino (All) 0.9644
Daily Value at Risk (VaR) 1% (All) 3.15%
Monthly Value at Risk (VaR) 1% (All) 14.49%

Fundamentals

Dividend Yield TTM (8-11-20) 1.22%
30-Day SEC Yield (8-11-20) 0.87%
7-Day SEC Yield (11-28-03) 0.00%
Weighted Average PE Ratio 14.80
Weighted Average Price to Sales Ratio 1.662
Weighted Average Price to Book Ratio 2.993
Weighted Median ROE 31.76%
Weighted Median ROA 11.13%
Forecasted Dividend Yield 2.11%
Forecasted PE Ratio 15.12
Forecasted Price to Sales Ratio 1.504
Forecasted Price to Book Ratio 2.842
Number of Holdings 145
As of March 31, 2020

Growth Estimates

Forecasted 5 Yr Earnings Growth 9.40%
Forecasted Book Value Growth 3.80%
Forecasted Cash Flow Growth 9.88%
Forecasted Earnings Growth 11.01%
Forecasted Revenue Growth 7.83%
As of March 31, 2020

Comparables

Edit

Attributes

Purchase Details
Open to New Investors No
Open to Existing Investors No
Minimum Initial Investment 3000.00 USD
Minimum Subsequent Investment 1.00 USD
Fees
Actual 12B-1 Fee --
Actual Management Fee 0.37%
Administration Fee --
Performance Fee --
Switching Fee --
Transaction Fee --
Maximum Front Load --
Maximum Deferred Load --
Maximum Redemption Fee --
Key Dates
Inception Date 11/1/1984
Termination Date
Last Annual Report Date 9/30/2019
Last Prospectus Date 1/31/2020
Attributes
Exchange Traded Share No
Exchange Traded Note No
Enhanced Index Fund No
Fixed Distribution Fund No
High-Net Worth Individual Fund No
Index Fund No
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
Socially Responsible Fund No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.